Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Receives $11.06 Average Target Price from Brokerages

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) has earned an average rating of “Hold” from the eleven brokerages that are covering the firm, MarketBeat Ratings reports. Six equities research analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 12 month price target among brokerages that have covered the stock in the last year is $11.0625.

AVAH has been the subject of several recent research reports. Zacks Research downgraded Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, February 3rd. Weiss Ratings reissued a “hold (c+)” rating on shares of Aveanna Healthcare in a research note on Monday, December 29th. Truist Financial lifted their target price on Aveanna Healthcare from $9.50 to $10.00 and gave the stock a “hold” rating in a report on Friday, November 7th. Royal Bank Of Canada increased their price target on Aveanna Healthcare from $10.00 to $11.00 and gave the company a “sector perform” rating in a research note on Thursday, January 15th. Finally, Barclays lifted their price objective on Aveanna Healthcare from $9.00 to $11.00 and gave the stock an “overweight” rating in a research note on Friday, January 16th.

Insider Activity

In other news, CEO Jeff Shaner sold 29,357 shares of Aveanna Healthcare stock in a transaction dated Friday, January 2nd. The stock was sold at an average price of $7.85, for a total value of $230,452.45. Following the completion of the transaction, the chief executive officer directly owned 2,394,179 shares of the company’s stock, valued at approximately $18,794,305.15. This trade represents a 1.21% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Patrick A. Cunningham sold 12,445 shares of the company’s stock in a transaction dated Friday, January 2nd. The shares were sold at an average price of $7.85, for a total value of $97,693.25. Following the sale, the insider owned 293,354 shares in the company, valued at approximately $2,302,828.90. The trade was a 4.07% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 259,638 shares of company stock worth $2,109,595 over the last quarter. Company insiders own 7.80% of the company’s stock.

Hedge Funds Weigh In On Aveanna Healthcare

A number of institutional investors and hedge funds have recently modified their holdings of AVAH. AQR Capital Management LLC increased its stake in shares of Aveanna Healthcare by 21.2% in the 1st quarter. AQR Capital Management LLC now owns 26,280 shares of the company’s stock valued at $142,000 after acquiring an additional 4,602 shares in the last quarter. Goldman Sachs Group Inc. increased its stake in Aveanna Healthcare by 8.3% in the first quarter. Goldman Sachs Group Inc. now owns 339,853 shares of the company’s stock valued at $1,842,000 after purchasing an additional 25,974 shares in the last quarter. Jane Street Group LLC raised its holdings in shares of Aveanna Healthcare by 522.0% during the first quarter. Jane Street Group LLC now owns 75,081 shares of the company’s stock valued at $407,000 after purchasing an additional 63,010 shares during the period. MQS Management LLC bought a new position in shares of Aveanna Healthcare during the 2nd quarter worth about $59,000. Finally, Belvedere Trading LLC acquired a new stake in shares of Aveanna Healthcare in the 2nd quarter valued at about $62,000. 87.96% of the stock is currently owned by institutional investors.

Aveanna Healthcare Stock Performance

Shares of NASDAQ AVAH opened at $7.93 on Thursday. The company has a debt-to-equity ratio of 140.39, a quick ratio of 1.23 and a current ratio of 1.23. Aveanna Healthcare has a 52 week low of $3.67 and a 52 week high of $10.32. The stock has a market capitalization of $1.66 billion, a PE ratio of 22.03 and a beta of 2.06. The stock has a 50 day moving average price of $8.60 and a 200 day moving average price of $8.37.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.